Keyword: cardiovascular

News

Bayer Plans to Scale Back Women’s Health R&D

27.03.2023 -

Ahead of a change in leadership at the top after the upcoming annual general meeting, in interviews with news agencies Bayer is dropping hints in dribbles about future...

News

AstraZeneca Sells Heart Drug Rights to Recordati

23.05.2017 - AstraZeneca has sold European rights for its Seloken/Seloken ZOK and Logimax cardiovascular drugs to Italy’s Recordati for $300 million. The medicines, which are used to treat...

News

Sanofi and Regeneron Appeal Praluent Sales Halt

11.01.2017 - French drugmaker Sanofi and US marketing partner Regeneron have announced they will appeal a ruling by a US federal district court judge that would prevent them from selling their...

Chemistry & Life Sciences

Scottish Ingenuity

29.01.2013 - A Raw Diamond - Soon after BASF acquired Cognis three years ago in a €3 billion deal, it set itself the objective of becoming a major global player in the world market for omega-3...